Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... Nature immunology 23 (1), 40-49, 2022 | 169 | 2022 |
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study … M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ... The Lancet Healthy Longevity 3 (1), e13-e21, 2022 | 89 | 2022 |
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an … G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, N Kaur, E Spalkova, ... The Lancet Healthy Longevity 2 (9), e544-e553, 2021 | 53 | 2021 |
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia H Parry, R Bruton, T Roberts, G McIlroy, S Damery, P Sylla, AC Dowell, ... Cancer Cell 40 (6), 584-586, 2022 | 23 | 2022 |
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study G Tut, T Lancaster, P Sylla, MS Butler, N Kaur, E Spalkova, C Bentley, ... The Lancet Healthy Longevity 3 (7), e461-e469, 2022 | 20 | 2022 |
S100P enhances the motility and invasion of human trophoblast cell lines MEA Tabrizi, TL Lancaster, TM Ismail, A Georgiadou, A Ganguly, JJ Mistry, ... Scientific Reports 8 (1), 11488, 2018 | 20 | 2018 |
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, E Spalkova, C Bentley, ... Nature Aging 3 (1), 93-104, 2023 | 13 | 2023 |
Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... | 12 | 2021 |
Immunological imprinting of humoral immunity to SARS-CoV-2 in children AC Dowell, T Lancaster, R Bruton, G Ireland, C Bentley, P Sylla, J Zuo, ... Nature Communications 14 (1), 3845, 2023 | 8 | 2023 |
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study … M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ... | 7 | 2022 |
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibody in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study … M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ... medRxiv, 2021.09. 27.21264166, 2021 | 7 | 2021 |
Severe acute respiratory syndrome coronavirus 2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 vaccine in residents of long-term care … O Stirrup, M Krutikov, G Tut, T Palmer, D Bone, R Bruton, C Fuller, B Azmi, ... The Journal of Infectious Diseases 226 (11), 1877-1881, 2022 | 5 | 2022 |
Primary Omicron infection elicits weak antibody response but robust cellular immunity in children AC Dowell, T Lancaster, R Bruton, G Ireland, C Bentley, P Sylla, J Zuo, ... bioRxiv, 2022.07. 26.501570, 2022 | 5 | 2022 |
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection G Tut, T Lancaster, MS Butler, P Sylla, E Spalkova, D Bone, N Kaur, ... Nature Aging 2 (6), 536-547, 2022 | 5 | 2022 |
Booster vaccination strongly enhances SARS-CoV-2-specific antibody and cellular responses in elderly residents of care homes G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, E Spalkova, C Bentley, ... | 5 | 2021 |
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an … G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, N Kaur, E Spalkova, ... DOI: https://doi. org/10.1016/S2666-7568 (21), 00168-9, 2021 | 5 | 2021 |
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI) O Stirrup, M Krutikov, G Tut, T Palmer, D Bone, R Bruton, C Fuller, B Azmi, ... medRxiv, 2022.01. 26.22269885, 2022 | 2 | 2022 |
Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities G Tut, T Lancaster, MS Butler, D Bone, N Kaur, E Spalkova, C Bentley, ... | 2 | 2021 |
The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis TM Ismail, SR Gross, T Lancaster, PS Rudland, R Barraclough Biomolecules 11 (10), 1471, 2021 | 2 | 2021 |
Children develop robust and sustained cross-reactive spike-specific immune responses following SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... medRxiv, 2021.04. 12.21255275, 2021 | 1 | 2021 |